Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease With Dr. Eoin P. Flanagan

Myelin Oligodendrocyte Glycoprotein Antibody–...

Up next

Neuromyelitis Optica Spectrum Disorder With Dr. Sara Mariotto

Although rare, recognizing NMOSD is crucial for improving patient outcomes through correct diagnostic and treatment approaches. Reports of atypical forms and increasing knowledge of clinical, imaging, and laboratory-specific features are fundamental for the accurate recognition o ...  Show more

Adult-Onset Leukodystrophies Mimicking Multiple Sclerosis With Dr. Roberta La Piana

Adult‑onset leukodystrophies, though rare, can closely mimic MS on both clinical presentation and neuroimaging, posing a significant diagnostic challenge. This episode highlights key clinical and radiologic red flags that can help distinguish these disorders from MS, preventing m ...  Show more

Recommended Episodes

Vitreopapillary Findings in Nonarteritic Ischemic Optic Neuropathy
Ophthalmology Journal

Dr. Drew Carey speaks with Dr. Tongalp H. Tezel on his study comparing patients with nonarteritic ischemic optic neuropathy (NAION) with healthy non-NAION patients with crowded discs and noncrowded optic discs. From his Ophthalmology article, "

  Show more

Ocular Manifestations of ROSAH Syndrome
Ophthalmology Journal

What is ROSAH syndrome and how does it affect the visual function of patients with it? Dr. Tsui discusses this with Drs. Laryssa A. Huryn and Shilpa Kodati, authors of the Ophthalmology article, "<a href= "https://www.aaojournal.org/article/S0161-642 ...

  Show more

Semaglutide and NAION
Experts InSight

Dr. Peter Quiros joins host Dr. Amanda Redfern to discuss the recent JAMA Ophthalmology article "The Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," the first study to report a possible association between semaglutide (Wegovy, Ozempic, ...  Show more

Novel Therapies in GI Oncology at ASCO23
ASCO Daily News

Drs. Shaalan Beg and Shiraj Sen discuss notable advances in GI cancers featured at the 2023 ASCO Annual Meeting, including the PROSPECT and PRODIGE-23 trials in rectal adenocarcinoma, the MORPHEUS study in uHCC, and the NORPACT-1 trial in pancreatic head cancer.

<span s ...

  Show more